Seahawks & Virginia Mason Franciscan Health Support NFL's Crucial Catch Initiative - Seattle Seahawks

UVA Health is expanding its advanced cardiovascular care capabilities as the first healthcare system in Virginia to offer a dedicated robotic cardiac surgery program. Led by Michael Ibrahim, MD, director of robotic cardiac surgery at UVA Health, the program brings cutting-edge, minimally invasive options for valve patients right now across Virginia and beyond. While robotic heart surgery was once limited to simple procedures, the program at UVA Health covers a broad spectrum of complex valve conditions as well as atrial fibrillation and coronary artery disease. The team's inaugural procedure demonstrated the clinical value of bringing this advanced technology to UVA Health. Rather than facing a traditional open-chest operation, the patient successfully underwent a robotic mitral valve repair. "This first patient was somewhere kind of in the middle. She had complex valve disease and was considering a transcatheter therapy versus surgery, “ says Ibrahim. “Because we were able to use surgery without having to open the chest, that's what she went with. And surgery is generally more durable and more definitively corrective than transcatheter therapy," he notes.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.